Is KNSA stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Kiniksa Pharmaceuticals 10 years ago, but if you had invested on Thursday 24th of May 2018 when the price was $19.47, you would have made a profit of $5.48 per share or 28.15%
Yes, the average daily trading liquidity for Kiniksa Pharmaceuticals is $9.17 million. You should therefore be able to get in and out of your positions relatively fast.
Kiniksa Pharmaceuticals has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 1.78, the company's ability to pay off the debt is good. The company has a very low net profit margin of 2.87%, which is challenging.
We have calculated the inflation risk for Kiniksa Pharmaceuticals to be low [0.2 out of 1]